DK0760648T3 - Flubendazoltyggetabletter til kæledyr - Google Patents

Flubendazoltyggetabletter til kæledyr

Info

Publication number
DK0760648T3
DK0760648T3 DK95919448T DK95919448T DK0760648T3 DK 0760648 T3 DK0760648 T3 DK 0760648T3 DK 95919448 T DK95919448 T DK 95919448T DK 95919448 T DK95919448 T DK 95919448T DK 0760648 T3 DK0760648 T3 DK 0760648T3
Authority
DK
Denmark
Prior art keywords
flubendazole
pct
pets
chewable tablets
sec
Prior art date
Application number
DK95919448T
Other languages
Danish (da)
English (en)
Inventor
Paul Marie Victor Gilis
Eugene Marie Jozef Jans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0760648T3 publication Critical patent/DK0760648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK95919448T 1994-05-20 1995-05-12 Flubendazoltyggetabletter til kæledyr DK0760648T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20
PCT/EP1995/001801 WO1995031963A1 (en) 1994-05-20 1995-05-12 Chewable flubendazole tablets for companion animals

Publications (1)

Publication Number Publication Date
DK0760648T3 true DK0760648T3 (da) 2002-02-25

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95919448T DK0760648T3 (da) 1994-05-20 1995-05-12 Flubendazoltyggetabletter til kæledyr

Country Status (23)

Country Link
US (1) US5824336A (sv)
EP (1) EP0760648B1 (sv)
JP (1) JPH10501211A (sv)
AT (1) ATE208611T1 (sv)
AU (1) AU690994B2 (sv)
BR (1) BR9507637A (sv)
CA (1) CA2190357C (sv)
CY (1) CY2255B1 (sv)
CZ (1) CZ290406B6 (sv)
DE (1) DE69523912T2 (sv)
DK (1) DK0760648T3 (sv)
ES (1) ES2167436T3 (sv)
FI (1) FI118324B (sv)
HK (1) HK1010695A1 (sv)
HU (1) HU225958B1 (sv)
IL (1) IL113782A (sv)
NO (1) NO313402B1 (sv)
NZ (1) NZ285766A (sv)
PL (1) PL185332B1 (sv)
PT (1) PT760648E (sv)
SI (1) SI0760648T1 (sv)
WO (1) WO1995031963A1 (sv)
ZA (1) ZA954128B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (en) * 2003-03-10 2007-09-12 Novartis AG Taste-masked solid veterinary compositions
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
BRPI0413394A8 (pt) 2003-08-26 2016-03-08 Shire Holdings Ag Formulação de lantânio mastigável em tablete, formulação farmacêutica em tablete ou em pó, método para tratar hiperfosfatemia, uso de uma quantidade terapeuticamente efetiva de uma formulação de um composto de lantânio, processo para preparar uma formulação em tablete de um composto de lantânio
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
PL3061454T3 (pl) 2012-02-06 2021-09-20 Boehringer Ingelheim Animal Health USA Inc. Pasożytobójcze doustne kompozycje weterynaryjne obejmujące systemowo działające środki aktywne, sposoby i ich zastosowania
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN104203214B (zh) 2012-04-04 2018-05-25 英特维特国际股份有限公司 软咀嚼药用产品
BR112015023435B1 (pt) 2013-03-15 2022-05-03 Douglas Robert Cleverly Formulação mastigável estável sob armazenagem e método de fabricação de uma formulação mastigável, palatável e estável sob armazenagem
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
CA3176466A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
DE69523912T2 (de) 2002-06-27
US5824336A (en) 1998-10-20
NZ285766A (en) 1997-09-22
CZ290406B6 (cs) 2002-07-17
CZ333596A3 (en) 1997-02-12
PL185332B1 (pl) 2003-04-30
FI964623A (sv) 1996-11-19
ATE208611T1 (de) 2001-11-15
IL113782A0 (en) 1995-08-31
IL113782A (en) 1999-08-17
NO964912D0 (no) 1996-11-19
ZA954128B (en) 1996-11-19
NO313402B1 (no) 2002-09-30
DE69523912D1 (de) 2001-12-20
PL317227A1 (en) 1997-03-17
EP0760648B1 (en) 2001-11-14
HU9603215D0 (en) 1997-01-28
JPH10501211A (ja) 1998-02-03
HUT74988A (en) 1997-03-28
FI964623A0 (sv) 1996-11-19
SI0760648T1 (en) 2002-04-30
PT760648E (pt) 2002-04-29
CY2255B1 (en) 2003-07-04
ES2167436T3 (es) 2002-05-16
FI118324B (sv) 2007-10-15
NO964912L (no) 1996-11-19
HU225958B1 (en) 2008-01-28
EP0760648A1 (en) 1997-03-12
CA2190357A1 (en) 1995-11-30
CA2190357C (en) 2007-04-17
AU690994B2 (en) 1998-05-07
AU2527295A (en) 1995-12-18
HK1010695A1 (en) 1999-06-25
BR9507637A (pt) 1997-10-07
WO1995031963A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
DK0760648T3 (da) Flubendazoltyggetabletter til kæledyr
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
AU7285487A (en) Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
BR0311970A (pt) Novos compostos, seu uso e preparação
MX2007003307A (es) 4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.
BR9612196A (pt) Tiazolinas substituidas
DE3776336D1 (de) Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
MX9605709A (es) Tabletas masticables de flubendazol para animales de compañia.
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
DE59809344D1 (de) Disubstituierte biphenyloxazoline
GB0003234D0 (en) Method of treatment
BR0014145A (pt) Compostos de benzimidazol substituìdo por alcóxi, preparações farmacêuticas contendo o mesmo, e métodos de uso do mesmo
ATE284397T1 (de) 5-(alkylidene-cycloalkyl)- und 5-(alkylidene- heterocyclyl)-pyrazole
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
DK0877598T3 (da) Anthelmintisk pasta
DE69217227D1 (de) Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung